Vara Secures CE Mark for 3D Mammography AI Platform
BERLIN, Germany, June 10, 2026 Vara has received CE Class IIb certification under the European Union Medical Device Regulation...
AI drug discovery Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BERLIN, Germany, June 10, 2026 Vara has received CE Class IIb certification under the European Union Medical Device Regulation...
BURLINGTON, Massachusetts, USA, April 28, 2026 SQ Innovation has announced that its drug-device combination therapy Lasix® ONYU has achieved...
Solana Beach, California | January 22, 2026 ClearPoint Neuro has announced the successful EU Medical Device Regulation (EU MDR)...
MINNEAPOLIS, Minnesota — December 15, 2025 — Medical 21, Inc., a privately held medical technology company, announced it has...
